Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E. Burkhardt, … , Edwin P. Alyea, Catherine J. Wu
Ute E. Burkhardt, … , Edwin P. Alyea, Catherine J. Wu
Published August 5, 2013
Citation Information: J Clin Invest. 2013;123(9):3756-3765. https://doi.org/10.1172/JCI69098.
View: Text | PDF
Clinical Research and Public Health Article has an altmetric score of 59

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells

  • Text
  • PDF
Abstract

Background. Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whether vaccination with whole leukemia cells early after transplantation facilitates the expansion of leukemia-reactive T cells and thereby enhances antitumor immunity.

Methods. We enrolled 22 patients with advanced chronic lymphocytic leukemia (CLL), 18 of whom received up to 6 vaccines initiated between days 30 and 45 after transplantation. Each vaccine consisted of irradiated autologous tumor cells admixed with GM-CSF–secreting bystander cells. Serial patient PBMC samples following transplantation were collected, and the impact of vaccination on T cell activity was evaluated.

Results. At a median follow-up of 2.9 (range, 1–4) years, the estimated 2-year progression-free and overall survival rates of vaccinated subjects were 82% (95% CI, 54%–94%) and 88% (95% CI, 59%–97%), respectively. Although vaccination only had a modest impact on recovering T cell numbers, CD8+ T cells from vaccinated patients consistently reacted against autologous tumor, but not alloantigen-bearing recipient cells with increased secretion of the effector cytokine IFN-γ, unlike T cells from nonvaccinated CLL patients undergoing allo-HSCT. Further analysis confirmed that 17% (range, 13%–33%) of CD8+ T cell clones isolated from 4 vaccinated patients by limiting dilution of bulk tumor-reactive T cells solely reacted against CLL-associated antigens.

Conclusion. Our studies suggest that autologous tumor cell vaccination is an effective strategy to advance long-term leukemia control following allo-HSCT.

Trial registration. Clinicaltrials.gov NCT00442130.

Funding. NCI (5R21CA115043-2), NHLBI (5R01HL103532-03), and Leukemia and Lymphoma Society Translational Research Program.

Authors

Ute E. Burkhardt, Ursula Hainz, Kristen Stevenson, Natalie R. Goldstein, Mildred Pasek, Masayasu Naito, Di Wu, Vincent T. Ho, Anselmo Alonso, Naa Norkor Hammond, Jessica Wong, Quinlan L. Sievers, Ana Brusic, Sean M. McDonough, Wanyong Zeng, Ann Perrin, Jennifer R. Brown, Christine M. Canning, John Koreth, Corey Cutler, Philippe Armand, Donna Neuberg, Jeng-Shin Lee, Joseph H. Antin, Richard C. Mulligan, Tetsuro Sasada, Jerome Ritz, Robert J. Soiffer, Glenn Dranoff, Edwin P. Alyea, Catherine J. Wu

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2009 Total
Citations: 1 1 1 3 2 1 4 4 6 4 8 2 1 38
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (38)

Title and authors Publication Year
Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines
Hushmandi K, Imani Fooladi AA, Reiter RJ, Farahani N, Liang L, Aref AR, Nabavi N, Alimohammadi M, Liu L, Sethi G
Experimental Hematology & Oncology 2025
Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials.
Bastin DJ, Montroy J, Kennedy MA, Martel AB, Shorr R, Ghiasi M, Boucher DM, Wong B, Gresham L, Diallo JS, Fergusson DA, Lalu MM, Kekre N, Auer RC
Scientific Reports 2023
The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia
Nagler A, Wu CJ
Blood 2022
60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy
N Cieri, K Maurer, CJ Wu
Cancer research 2021
Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives
M Kwok, A Agathanggelou, N Davies, T Stankovic
Cancers 2021
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas
MS Sasso, N Mitrousis, Y Wang, PS Briquez, S Hauert, J Ishihara, JA Hubbell, MA Swartz
Science Advances 2021
Personal tumor antigens in blood malignancies: genomics-directed identification and targeting
Livius Penter, Catherine J. Wu
Journal of Clinical Investigation 2020
Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews
ST Khan, J Montroy, N Forbes, D Bastin, MA Kennedy, JS Diallo, N Kekre, DA Fergusson, M Lalu, RC Auer
BMJ Open 2020
Atraumatic splenic ruptures triggered both remission and death in a single case of blastic plasmacytoid dendritic cell neoplasm
S Daitoku, M Onimaru, K Tanimoto, M Kuroiwa
Journal of Clinical and Experimental Hematopathology 2019
Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues
BS Hanna, PM Roessner, H Yazdanparast, D Colomer, E Campo, S Kugler, D Yosifov, S Stilgenbauer, M Schmidt, R Gabriel, P Lichter, M Seiffert
Leukemia 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients
TM Robinson, GT Prince, C Thoburn, E Warlick, A Ferguson, YL Kasamon, IM Borrello, A Hess, BD Smith
Leukemia & Lymphoma 2018
A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression
HE Stefanski, L Jonart, E Goren, JJ Mulé, BR Blazar, N Labrecque
PloS one 2018
Cancer immune therapy for lymphoid malignancies: recent advances
U Klausen, NG Jørgensen, JH Grauslund, MO Holmström, MH Andersen
Seminars in Immunopathology 2018
Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia
Q Yin, M Sivina, H Robins, E Yusko, M Vignali, S OBrien, MJ Keating, A Ferrajoli, Z Estrov, N Jain, WG Wierda, JA Burger
Journal of immunology (Baltimore, Md. : 1950) 2017
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Z Hu, PA Ott, CJ Wu
Nature Reviews Immunology 2017
Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies:
DA Braun, CJ Wu
The Cancer Journal 2017
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT
VT Ho, HT Kim, N Bavli, M Mihm, O Pozdnyakova, M Piesche, H Daley, C Reynolds, NC Souders, C Cutler, J Koreth, EP Alyea, JH Antin, J Ritz, G Dranoff, RJ Soiffer
Blood Advances 2017
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
WT Curry, R Gorrepati, M Piesche, T Sasada, P Agarwalla, PS Jones, ER Gerstner, AJ Golby, TT Batchelor, PY Wen, MC Mihm, G Dranoff
Clinical cancer research 2016
Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients
N Hosen, T Maeda, Y Hashii, A Tsuboi, S Nishida, J Nakata, Y Oji, Y Oka, H Sugiyama
Stem Cell Investigation 2016
Advances in Experimental Medicine and Biology
NR Harrison, FJ Laroche, A Gutierrez, H Feng
Advances in experimental medicine and biology 2016
GIFT4 fusokine converts leukemic B cells into immune helper cells
J Deng, A Pennati, JB Cohen, Y Wu, S Ng, JH Wu, CR Flowers, J Galipeau
Journal of Translational Medicine 2016
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, R Straussman, G Eisenberg, S Frankenburg, E Carmon, B Alaiyan, S Shneibaum, ZO Ayyildiz, M Isbilen, KM Senses, I Ron, H Steinberg, Y Smith, E Shiloni, AO Gure, T Peretz
Journal of Immunology Research 2016
Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia
PA Toniolo, S Liu, JE Yeh, DQ Ye, JA Barbuto, DA Frank
Oncotarget 2016
Haematological malignancies: at the forefront of immunotherapeutic innovation
P Bachireddy, UE Burkhardt, M Rajasagi, CJ Wu
Nature Reviews Cancer 2015
PD-L1 Checkpoint Blockade Prevents Immune Dysfunction and Leukemia Development in a Mouse Model of Chronic Lymphocytic Leukemia
F McClanahan, B Hanna, S Miller, AJ Clear, P Lichter, JG Gribben, M Seiffert
Blood 2015
Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy
HH Cheng, C Soleau, EY Yu
Journal of Hematology & Oncology 2015
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia
R Guieze, CJ Wu
Blood 2015
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
M Rajasagi, SA Shukla, EF Fritsch, DB Keskin, D DeLuca, E Carmona, W Zhang, C Sougnez, K Cibulskis, J Sidney, K Stevenson, J Ritz, D Neuberg, V Brusic, S Gabriel, ES Lander, G Getz, N Hacohen, CJ Wu
Blood 2014
Understanding anti-leukemia responses to donor lymphocyte infusion
P Bachireddy, CJ Wu
OncoImmunology 2014
Personal neoantigen cancer vaccines: The momentum builds
EF Fritsch, N Hacohen, CJ Wu
OncoImmunology 2014
Allogeneic stem cell transplantation in chronic lymphocytic leukemia patients with 17p deletion: consult-transplant v consult-no-transplant analysis
ML Poon, PS Fox, BI Samuels, S O’Brien, E Jabbour, Y Hsu, A Gulbis, M Korbling, R Champlin, LV Abruzzo, RL Bassett, IF Khouri
Leukemia & Lymphoma 2014
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
DJ Kowalewski, H Schuster, L Backert, C Berlin, S Kahn, L Kanz, HR Salih, HG Rammensee, S Stevanovic, JS Stickel
Proceedings of the National Academy of Sciences 2014
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
AR Pyzer, DE Avigan, J Rosenblatt
Human Vaccines & Immunotherapeutics 2014
Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
I Henig, T Zuckerman
Rambam Maimonides Medical Journal 2014
Cancer Immunoprevention--The Next Frontier
MA Smit, EM Jaffee, ER Lutz
Cancer prevention research (Philadelphia, Pa.) 2014
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors
MA Kharfan-Dabaja, WG Wierda, LJ Cooper
Leukemia 2013
Boosting leukemia-specific T cell responses in patients following stem cell transplantation
UE Burkhardt, CJ Wu
OncoImmunology 2013
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 8 news outlets
Posted by 8 X users
Referenced in 12 patents
On 1 Facebook pages
84 readers on Mendeley
1 readers on CiteULike
See more details